Pyush Moudgil

Ramnagar, UP, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Pre-emptive and Prophylactic Strategies to Prevent Cardiovascular and Neurotoxicity in Chimeric Antigen Receptor T-Cell Therapy: The Role of Tocilizumab, Anakinra, and Cytokine-Targeted Interventions.

Pre-emptive and Prophylactic Strategies to Prevent Cardiovascular and Neurotoxicity in Chimeric Antigen Receptor T-Cell Therapy: The Role of Tocilizumab, Anakinra, and Cytokine-Targeted Interventions.

Journal: Cardiology in review

Published: May 26, 2026

Cardiac Arrhythmias Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Cardiac Arrhythmias Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Journal: Cardiology in review

Published: May 26, 2026

Frailty, Sarcopenia, and Functional Decline After CAR-T Therapy: The Case for Structured Rehabilitation.

Frailty, Sarcopenia, and Functional Decline After CAR-T Therapy: The Case for Structured Rehabilitation.

Journal: Cardiology in review

Published: May 18, 2026

Global Longitudinal Strain as a Surveillance Tool in Hematologic Cancer-Related Cardiotoxicity.

Global Longitudinal Strain as a Surveillance Tool in Hematologic Cancer-Related Cardiotoxicity.

Journal: Cardiology in review

Published: May 06, 2026

Myeloproliferative Neoplasms, Clonal Thrombosis, and Vascular Disease: Can Cardiology Learn from Hematology?

Myeloproliferative Neoplasms, Clonal Thrombosis, and Vascular Disease: Can Cardiology Learn from Hematology?

Journal: Cardiology in review

Published: April 30, 2026

Cancer-Associated Takotsubo Syndrome: An Emerging Intersection of Cardio-Oncology.

Cancer-Associated Takotsubo Syndrome: An Emerging Intersection of Cardio-Oncology.

Journal: Cardiology in review

Published: April 06, 2026

Clonal Cytopenias of Undetermined Significance and Cardiovascular Disease: Inflammatory Mechanisms, Risk Stratification, and Clinical Outcomes.

Clonal Cytopenias of Undetermined Significance and Cardiovascular Disease: Inflammatory Mechanisms, Risk Stratification, and Clinical Outcomes.

Journal: Cardiology in review

Published: April 03, 2026

Poly(ADP-Ribose) Polymerases Inhibition in Cardiovascular Oncology: Protective Mechanisms Versus Clinical Cardiotoxicity.

Poly(ADP-Ribose) Polymerases Inhibition in Cardiovascular Oncology: Protective Mechanisms Versus Clinical Cardiotoxicity.

Journal: Cardiology in review

Published: March 31, 2026

Immune Checkpoint Inhibitor-Associated Myocarditis: Current Understanding of Clinical Presentation and Management.

Immune Checkpoint Inhibitor-Associated Myocarditis: Current Understanding of Clinical Presentation and Management.

Journal: Cardiology in review

Published: March 31, 2026

Second-Generation and Off-the-Shelf CAR Platforms: Emerging Cardiovascular Implications of Next-Generation Cellular Immunotherapies.

Second-Generation and Off-the-Shelf CAR Platforms: Emerging Cardiovascular Implications of Next-Generation Cellular Immunotherapies.

Journal: Cardiology in review

Published: March 16, 2026

VEGF Inhibitors in Hematologic Cancers and Hypertension/Cardiac Effects.

VEGF Inhibitors in Hematologic Cancers and Hypertension/Cardiac Effects.

Journal: Cardiology in review

Published: February 25, 2026

Circulating Tumor DNA and Blood-Based Biomarkers for Predicting Cardiotoxicity in Cancer Therapy: Toward Precision Cardio-Oncology.

Circulating Tumor DNA and Blood-Based Biomarkers for Predicting Cardiotoxicity in Cancer Therapy: Toward Precision Cardio-Oncology.

Journal: Cardiology in review

Published: February 19, 2026

Showing 1-12 of 15

Last Updated: 09/26/2026